Key points are not available for this paper at this time.
This study reveals a previously unrecognized LD-mitochondrial regulatory axis underlying CIH-associated PD pathology and highlights its potential as a therapeutic target against CIH-accelerated neurodegeneration.
Zhai et al. (Sat,) studied this question.